nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—HTR1D—migraine	0.235	0.485	CbGaD
Frovatriptan—HTR1B—migraine	0.139	0.288	CbGaD
Frovatriptan—HTR1A—migraine	0.11	0.228	CbGaD
Frovatriptan—HTR1B—Propranolol—migraine	0.0649	0.211	CbGbCtD
Frovatriptan—HTR1D—Amitriptyline—migraine	0.0585	0.19	CbGbCtD
Frovatriptan—HTR1B—Amitriptyline—migraine	0.0561	0.182	CbGbCtD
Frovatriptan—HTR1A—Propranolol—migraine	0.0406	0.132	CbGbCtD
Frovatriptan—HTR1A—Amitriptyline—migraine	0.0351	0.114	CbGbCtD
Frovatriptan—CYP1A2—Propranolol—migraine	0.0157	0.051	CbGbCtD
Frovatriptan—CYP1A2—Amitriptyline—migraine	0.0136	0.0441	CbGbCtD
Frovatriptan—CYP1A2—Valproic Acid—migraine	0.0124	0.0402	CbGbCtD
Frovatriptan—HTR1B—trigeminal nucleus—migraine	0.0108	0.186	CbGeAlD
Frovatriptan—CYP1A2—Verapamil—migraine	0.0108	0.035	CbGbCtD
Frovatriptan—HTR1D—trigeminal nucleus—migraine	0.0104	0.18	CbGeAlD
Frovatriptan—HTR1D—meninx—migraine	0.00693	0.119	CbGeAlD
Frovatriptan—HTR1B—dura mater—migraine	0.00659	0.113	CbGeAlD
Frovatriptan—HTR1D—dura mater—migraine	0.00638	0.11	CbGeAlD
Frovatriptan—HTR1B—trigeminal nerve—migraine	0.00283	0.0487	CbGeAlD
Frovatriptan—HTR1D—trigeminal nerve—migraine	0.00274	0.0472	CbGeAlD
Frovatriptan—HTR1B—cranial nerve—migraine	0.00202	0.0347	CbGeAlD
Frovatriptan—HTR1D—cranial nerve—migraine	0.00195	0.0336	CbGeAlD
Frovatriptan—HTR1B—blood vessel—migraine	0.000812	0.014	CbGeAlD
Frovatriptan—HTR1D—blood vessel—migraine	0.000786	0.0135	CbGeAlD
Frovatriptan—HTR1B—trigeminal ganglion—migraine	0.000502	0.00863	CbGeAlD
Frovatriptan—HTR1D—Amine ligand-binding receptors—HTR1B—migraine	0.000493	0.00902	CbGpPWpGaD
Frovatriptan—HTR1D—trigeminal ganglion—migraine	0.000486	0.00836	CbGeAlD
Frovatriptan—HTR1D—Monoamine GPCRs—HTR7—migraine	0.000477	0.00873	CbGpPWpGaD
Frovatriptan—HTR1D—Amine ligand-binding receptors—HTR1A—migraine	0.000474	0.00868	CbGpPWpGaD
Frovatriptan—HTR1B—Monoamine GPCRs—HTR7—migraine	0.000467	0.00855	CbGpPWpGaD
Frovatriptan—HTR1B—Amine ligand-binding receptors—HTR1A—migraine	0.000464	0.0085	CbGpPWpGaD
Frovatriptan—HTR1D—Amine ligand-binding receptors—HTR2C—migraine	0.000458	0.00838	CbGpPWpGaD
Frovatriptan—HTR1B—Amine ligand-binding receptors—HTR2C—migraine	0.000448	0.00821	CbGpPWpGaD
Frovatriptan—HTR1B—brainstem—migraine	0.000444	0.00764	CbGeAlD
Frovatriptan—HTR1A—Monoamine GPCRs—HTR1B—migraine	0.000437	0.008	CbGpPWpGaD
Frovatriptan—HTR1D—brainstem—migraine	0.00043	0.0074	CbGeAlD
Frovatriptan—HTR1A—Monoamine GPCRs—HTR2C—migraine	0.000406	0.00744	CbGpPWpGaD
Frovatriptan—HTR1D—Amine ligand-binding receptors—HTR7—migraine	0.000401	0.00734	CbGpPWpGaD
Frovatriptan—HTR1B—Amine ligand-binding receptors—HTR7—migraine	0.000393	0.00719	CbGpPWpGaD
Frovatriptan—HTR1A—Amine ligand-binding receptors—HTR1B—migraine	0.000367	0.00673	CbGpPWpGaD
Frovatriptan—HTR1B—cardiovascular system—migraine	0.000362	0.00623	CbGeAlD
Frovatriptan—HTR1A—brainstem—migraine	0.000358	0.00616	CbGeAlD
Frovatriptan—HTR1A—Monoamine GPCRs—HTR7—migraine	0.000356	0.00651	CbGpPWpGaD
Frovatriptan—HTR1D—cardiovascular system—migraine	0.000351	0.00604	CbGeAlD
Frovatriptan—HTR1A—Amine ligand-binding receptors—HTR2C—migraine	0.000342	0.00625	CbGpPWpGaD
Frovatriptan—HTR1D—Monoamine GPCRs—HTR2A—migraine	0.000334	0.00612	CbGpPWpGaD
Frovatriptan—HTR1B—Monoamine GPCRs—HTR2A—migraine	0.000327	0.00599	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.0003	0.0055	CbGpPWpGaD
Frovatriptan—HTR1A—Amine ligand-binding receptors—HTR7—migraine	0.000299	0.00548	CbGpPWpGaD
Frovatriptan—HTR1A—cardiovascular system—migraine	0.000292	0.00503	CbGeAlD
Frovatriptan—HTR1D—Amine ligand-binding receptors—HTR2A—migraine	0.000281	0.00514	CbGpPWpGaD
Frovatriptan—HTR1B—Amine ligand-binding receptors—HTR2A—migraine	0.000275	0.00503	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—HTR3A—migraine	0.000255	0.00468	CbGpPWpGaD
Frovatriptan—HTR1A—Monoamine GPCRs—HTR2A—migraine	0.000249	0.00456	CbGpPWpGaD
Frovatriptan—HTR1B—head—migraine	0.000245	0.00422	CbGeAlD
Frovatriptan—HTR1D—head—migraine	0.000237	0.00409	CbGeAlD
Frovatriptan—HTR1B—nervous system—migraine	0.000233	0.004	CbGeAlD
Frovatriptan—HTR1D—nervous system—migraine	0.000225	0.00387	CbGeAlD
Frovatriptan—HTR1B—central nervous system—migraine	0.000224	0.00385	CbGeAlD
Frovatriptan—HTR1D—central nervous system—migraine	0.000217	0.00373	CbGeAlD
Frovatriptan—HTR1A—Amine ligand-binding receptors—HTR2A—migraine	0.00021	0.00384	CbGpPWpGaD
Frovatriptan—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000202	0.0037	CbGpPWpGaD
Frovatriptan—HTR1A—head—migraine	0.000198	0.00341	CbGeAlD
Frovatriptan—HTR1B—G alpha (i) signalling events—HTR1D—migraine	0.000197	0.0036	CbGpPWpGaD
Frovatriptan—HTR1A—nervous system—migraine	0.000188	0.00323	CbGeAlD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000183	0.00335	CbGpPWpGaD
Frovatriptan—HTR1A—central nervous system—migraine	0.000181	0.00311	CbGeAlD
Frovatriptan—HTR1B—brain—migraine	0.000178	0.00306	CbGeAlD
Frovatriptan—HTR1A—cerebellum—migraine	0.000177	0.00304	CbGeAlD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000174	0.00318	CbGpPWpGaD
Frovatriptan—HTR1D—brain—migraine	0.000172	0.00296	CbGeAlD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00017	0.00311	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CALCRL—migraine	0.000168	0.00307	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—RAMP1—migraine	0.000168	0.00307	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—RAMP1—migraine	0.000164	0.003	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CALCRL—migraine	0.000164	0.003	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000157	0.00287	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—HTR1D—migraine	0.00015	0.00275	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000149	0.00272	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000146	0.00266	CbGpPWpGaD
Frovatriptan—HTR1A—brain—migraine	0.000143	0.00247	CbGeAlD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000139	0.00255	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000129	0.00237	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—RAMP1—migraine	0.000125	0.00229	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CALCRL—migraine	0.000125	0.00229	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—HTR1B—migraine	0.000122	0.00223	CbGpPWpGaD
Frovatriptan—Muscular weakness—Topiramate—migraine	0.000121	0.00127	CcSEcCtD
Frovatriptan—Dizziness—Amitriptyline—migraine	0.00012	0.00126	CcSEcCtD
Frovatriptan—Dyspepsia—Verapamil—migraine	0.00012	0.00126	CcSEcCtD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TAC1—migraine	0.00012	0.00219	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000119	0.00218	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR1D—migraine	0.000119	0.00218	CbGpPWpGaD
Frovatriptan—Mental disorder—Valproic Acid—migraine	0.000119	0.00125	CcSEcCtD
Frovatriptan—Dysphagia—Topiramate—migraine	0.000118	0.00124	CcSEcCtD
Frovatriptan—Epistaxis—Gabapentin—migraine	0.000118	0.00124	CcSEcCtD
Frovatriptan—Malnutrition—Valproic Acid—migraine	0.000118	0.00124	CcSEcCtD
Frovatriptan—Sinusitis—Gabapentin—migraine	0.000118	0.00124	CcSEcCtD
Frovatriptan—HTR1D—G alpha (i) signalling events—HTR1A—migraine	0.000117	0.00215	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000117	0.00215	CbGpPWpGaD
Frovatriptan—Fatigue—Verapamil—migraine	0.000117	0.00123	CcSEcCtD
Frovatriptan—Abdominal pain—Propranolol—migraine	0.000117	0.00123	CcSEcCtD
Frovatriptan—Body temperature increased—Propranolol—migraine	0.000117	0.00123	CcSEcCtD
Frovatriptan—Visual impairment—Timolol—migraine	0.000116	0.00122	CcSEcCtD
Frovatriptan—Flatulence—Valproic Acid—migraine	0.000116	0.00122	CcSEcCtD
Frovatriptan—Pain—Verapamil—migraine	0.000116	0.00122	CcSEcCtD
Frovatriptan—Constipation—Verapamil—migraine	0.000116	0.00122	CcSEcCtD
Frovatriptan—Tension—Valproic Acid—migraine	0.000116	0.00122	CcSEcCtD
Frovatriptan—Dysgeusia—Valproic Acid—migraine	0.000116	0.00122	CcSEcCtD
Frovatriptan—Vomiting—Amitriptyline—migraine	0.000115	0.00121	CcSEcCtD
Frovatriptan—Sweating increased—Topiramate—migraine	0.000115	0.00121	CcSEcCtD
Frovatriptan—HTR1B—G alpha (i) signalling events—HTR1A—migraine	0.000115	0.0021	CbGpPWpGaD
Frovatriptan—Nervousness—Valproic Acid—migraine	0.000115	0.00121	CcSEcCtD
Frovatriptan—Bradycardia—Gabapentin—migraine	0.000114	0.00121	CcSEcCtD
Frovatriptan—Back pain—Valproic Acid—migraine	0.000114	0.0012	CcSEcCtD
Frovatriptan—Headache—Amitriptyline—migraine	0.000114	0.0012	CcSEcCtD
Frovatriptan—Muscle spasms—Valproic Acid—migraine	0.000114	0.0012	CcSEcCtD
Frovatriptan—HTR1D—GPCR ligand binding—HTR2B—migraine	0.000113	0.00207	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000113	0.00207	CbGpPWpGaD
Frovatriptan—Rhinitis—Gabapentin—migraine	0.000113	0.00119	CcSEcCtD
Frovatriptan—Tinnitus—Timolol—migraine	0.000113	0.00119	CcSEcCtD
Frovatriptan—Haemorrhage—Gabapentin—migraine	0.000112	0.00118	CcSEcCtD
Frovatriptan—Feeling abnormal—Verapamil—migraine	0.000112	0.00118	CcSEcCtD
Frovatriptan—Hypoaesthesia—Gabapentin—migraine	0.000112	0.00118	CcSEcCtD
Frovatriptan—Pharyngitis—Gabapentin—migraine	0.000112	0.00117	CcSEcCtD
Frovatriptan—Urinary tract disorder—Gabapentin—migraine	0.000111	0.00117	CcSEcCtD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000111	0.00203	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR2B—migraine	0.000111	0.00203	CbGpPWpGaD
Frovatriptan—Tremor—Valproic Acid—migraine	0.000111	0.00116	CcSEcCtD
Frovatriptan—Urethral disorder—Gabapentin—migraine	0.00011	0.00116	CcSEcCtD
Frovatriptan—Ill-defined disorder—Valproic Acid—migraine	0.00011	0.00115	CcSEcCtD
Frovatriptan—Pollakiuria—Topiramate—migraine	0.000109	0.00115	CcSEcCtD
Frovatriptan—Hypersensitivity—Propranolol—migraine	0.000109	0.00115	CcSEcCtD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000109	0.00199	CbGpPWpGaD
Frovatriptan—Agitation—Valproic Acid—migraine	0.000109	0.00114	CcSEcCtD
Frovatriptan—Visual impairment—Gabapentin—migraine	0.000108	0.00114	CcSEcCtD
Frovatriptan—Arrhythmia—Timolol—migraine	0.000108	0.00114	CcSEcCtD
Frovatriptan—Nausea—Amitriptyline—migraine	0.000108	0.00113	CcSEcCtD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000107	0.00195	CbGpPWpGaD
Frovatriptan—Malaise—Valproic Acid—migraine	0.000106	0.00112	CcSEcCtD
Frovatriptan—Vertigo—Valproic Acid—migraine	0.000106	0.00112	CcSEcCtD
Frovatriptan—Asthenia—Propranolol—migraine	0.000106	0.00112	CcSEcCtD
Frovatriptan—Mental disorder—Timolol—migraine	0.000106	0.00111	CcSEcCtD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000105	0.00192	CbGpPWpGaD
Frovatriptan—Malnutrition—Timolol—migraine	0.000105	0.00111	CcSEcCtD
Frovatriptan—Depression—Topiramate—migraine	0.000105	0.00111	CcSEcCtD
Frovatriptan—Tinnitus—Gabapentin—migraine	0.000105	0.0011	CcSEcCtD
Frovatriptan—Palpitations—Valproic Acid—migraine	0.000104	0.0011	CcSEcCtD
Frovatriptan—Tension—Timolol—migraine	0.000103	0.00109	CcSEcCtD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000103	0.00188	CbGpPWpGaD
Frovatriptan—Dysgeusia—Timolol—migraine	0.000103	0.00108	CcSEcCtD
Frovatriptan—Stomatitis—Topiramate—migraine	0.000103	0.00108	CcSEcCtD
Frovatriptan—Conjunctivitis—Topiramate—migraine	0.000102	0.00108	CcSEcCtD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000102	0.00187	CbGpPWpGaD
Frovatriptan—Nervousness—Timolol—migraine	0.000102	0.00107	CcSEcCtD
Frovatriptan—Diarrhoea—Propranolol—migraine	0.000101	0.00106	CcSEcCtD
Frovatriptan—Chills—Gabapentin—migraine	0.000101	0.00106	CcSEcCtD
Frovatriptan—Arthralgia—Valproic Acid—migraine	0.000101	0.00106	CcSEcCtD
Frovatriptan—Chest pain—Valproic Acid—migraine	0.000101	0.00106	CcSEcCtD
Frovatriptan—Myalgia—Valproic Acid—migraine	0.000101	0.00106	CcSEcCtD
Frovatriptan—Anxiety—Valproic Acid—migraine	0.0001	0.00105	CcSEcCtD
Frovatriptan—Hypersensitivity—Verapamil—migraine	0.0001	0.00105	CcSEcCtD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.0001	0.00183	CbGpPWpGaD
Frovatriptan—Epistaxis—Topiramate—migraine	9.94e-05	0.00105	CcSEcCtD
Frovatriptan—Discomfort—Valproic Acid—migraine	9.93e-05	0.00105	CcSEcCtD
Frovatriptan—Sinusitis—Topiramate—migraine	9.89e-05	0.00104	CcSEcCtD
Frovatriptan—Mental disorder—Gabapentin—migraine	9.85e-05	0.00104	CcSEcCtD
Frovatriptan—Dry mouth—Valproic Acid—migraine	9.83e-05	0.00103	CcSEcCtD
Frovatriptan—Malnutrition—Gabapentin—migraine	9.79e-05	0.00103	CcSEcCtD
Frovatriptan—Dizziness—Propranolol—migraine	9.77e-05	0.00103	CcSEcCtD
Frovatriptan—Asthenia—Verapamil—migraine	9.75e-05	0.00103	CcSEcCtD
Frovatriptan—Confusional state—Valproic Acid—migraine	9.72e-05	0.00102	CcSEcCtD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	9.69e-05	0.00177	CbGpPWpGaD
Frovatriptan—Flatulence—Gabapentin—migraine	9.65e-05	0.00102	CcSEcCtD
Frovatriptan—Anaphylactic shock—Valproic Acid—migraine	9.64e-05	0.00101	CcSEcCtD
Frovatriptan—Bradycardia—Topiramate—migraine	9.63e-05	0.00101	CcSEcCtD
Frovatriptan—Pruritus—Verapamil—migraine	9.62e-05	0.00101	CcSEcCtD
Frovatriptan—Tension—Gabapentin—migraine	9.61e-05	0.00101	CcSEcCtD
Frovatriptan—Dysgeusia—Gabapentin—migraine	9.59e-05	0.00101	CcSEcCtD
Frovatriptan—Haemoglobin—Topiramate—migraine	9.51e-05	0.001	CcSEcCtD
Frovatriptan—Nervousness—Gabapentin—migraine	9.51e-05	0.001	CcSEcCtD
Frovatriptan—Rhinitis—Topiramate—migraine	9.49e-05	0.000998	CcSEcCtD
Frovatriptan—HTR1D—GPCR downstream signaling—CALCRL—migraine	9.47e-05	0.00173	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—RAMP1—migraine	9.47e-05	0.00173	CbGpPWpGaD
Frovatriptan—Back pain—Gabapentin—migraine	9.47e-05	0.000997	CcSEcCtD
Frovatriptan—Haemorrhage—Topiramate—migraine	9.46e-05	0.000996	CcSEcCtD
Frovatriptan—Vertigo—Timolol—migraine	9.45e-05	0.000994	CcSEcCtD
Frovatriptan—Syncope—Timolol—migraine	9.43e-05	0.000992	CcSEcCtD
Frovatriptan—Hypoaesthesia—Topiramate—migraine	9.41e-05	0.000991	CcSEcCtD
Frovatriptan—Muscle spasms—Gabapentin—migraine	9.41e-05	0.000991	CcSEcCtD
Frovatriptan—Tachycardia—Valproic Acid—migraine	9.41e-05	0.00099	CcSEcCtD
Frovatriptan—Vomiting—Propranolol—migraine	9.4e-05	0.000989	CcSEcCtD
Frovatriptan—Pharyngitis—Topiramate—migraine	9.39e-05	0.000988	CcSEcCtD
Frovatriptan—Urinary tract disorder—Topiramate—migraine	9.34e-05	0.000983	CcSEcCtD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	9.33e-05	0.00171	CbGpPWpGaD
Frovatriptan—Hyperhidrosis—Valproic Acid—migraine	9.32e-05	0.000981	CcSEcCtD
Frovatriptan—Diarrhoea—Verapamil—migraine	9.3e-05	0.000979	CcSEcCtD
Frovatriptan—Palpitations—Timolol—migraine	9.29e-05	0.000978	CcSEcCtD
Frovatriptan—HTR1B—GPCR downstream signaling—CALCRL—migraine	9.28e-05	0.0017	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—RAMP1—migraine	9.28e-05	0.0017	CbGpPWpGaD
Frovatriptan—Urethral disorder—Topiramate—migraine	9.28e-05	0.000976	CcSEcCtD
Frovatriptan—Loss of consciousness—Timolol—migraine	9.24e-05	0.000973	CcSEcCtD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR7—migraine	9.21e-05	0.00169	CbGpPWpGaD
Frovatriptan—Anorexia—Valproic Acid—migraine	9.19e-05	0.000967	CcSEcCtD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	9.19e-05	0.00168	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	9.19e-05	0.00168	CbGpPWpGaD
Frovatriptan—Tremor—Gabapentin—migraine	9.17e-05	0.000965	CcSEcCtD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	9.13e-05	0.00167	CbGpPWpGaD
Frovatriptan—Visual impairment—Topiramate—migraine	9.12e-05	0.00096	CcSEcCtD
Frovatriptan—HTR1A—G alpha (i) signalling events—HTR1B—migraine	9.09e-05	0.00166	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR1D—migraine	9.08e-05	0.00166	CbGpPWpGaD
Frovatriptan—Ill-defined disorder—Gabapentin—migraine	9.08e-05	0.000956	CcSEcCtD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	9.02e-05	0.00165	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	9.01e-05	0.00165	CbGpPWpGaD
Frovatriptan—Agitation—Gabapentin—migraine	9e-05	0.000947	CcSEcCtD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	8.99e-05	0.00165	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	8.99e-05	0.00165	CbGpPWpGaD
Frovatriptan—Dizziness—Verapamil—migraine	8.99e-05	0.000946	CcSEcCtD
Frovatriptan—Chest pain—Timolol—migraine	8.95e-05	0.000942	CcSEcCtD
Frovatriptan—Arthralgia—Timolol—migraine	8.95e-05	0.000942	CcSEcCtD
Frovatriptan—Myalgia—Timolol—migraine	8.95e-05	0.000942	CcSEcCtD
Frovatriptan—Anxiety—Timolol—migraine	8.92e-05	0.000939	CcSEcCtD
Frovatriptan—Discomfort—Timolol—migraine	8.84e-05	0.000931	CcSEcCtD
Frovatriptan—Malaise—Gabapentin—migraine	8.83e-05	0.000929	CcSEcCtD
Frovatriptan—Tinnitus—Topiramate—migraine	8.82e-05	0.000928	CcSEcCtD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	8.82e-05	0.00161	CbGpPWpGaD
Frovatriptan—Vertigo—Gabapentin—migraine	8.8e-05	0.000926	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Valproic Acid—migraine	8.78e-05	0.000924	CcSEcCtD
Frovatriptan—Flushing—Topiramate—migraine	8.78e-05	0.000924	CcSEcCtD
Frovatriptan—Syncope—Gabapentin—migraine	8.78e-05	0.000924	CcSEcCtD
Frovatriptan—Nausea—Propranolol—migraine	8.78e-05	0.000924	CcSEcCtD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	8.76e-05	0.0016	CbGpPWpGaD
Frovatriptan—Dry mouth—Timolol—migraine	8.75e-05	0.000921	CcSEcCtD
Frovatriptan—Insomnia—Valproic Acid—migraine	8.72e-05	0.000917	CcSEcCtD
Frovatriptan—Paraesthesia—Valproic Acid—migraine	8.65e-05	0.000911	CcSEcCtD
Frovatriptan—Palpitations—Gabapentin—migraine	8.65e-05	0.000911	CcSEcCtD
Frovatriptan—Confusional state—Timolol—migraine	8.65e-05	0.000911	CcSEcCtD
Frovatriptan—Vomiting—Verapamil—migraine	8.64e-05	0.00091	CcSEcCtD
Frovatriptan—Loss of consciousness—Gabapentin—migraine	8.6e-05	0.000906	CcSEcCtD
Frovatriptan—HTR1D—Signaling by GPCR—CALCRL—migraine	8.6e-05	0.00157	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—RAMP1—migraine	8.6e-05	0.00157	CbGpPWpGaD
Frovatriptan—Dyspnoea—Valproic Acid—migraine	8.59e-05	0.000904	CcSEcCtD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	8.58e-05	0.00157	CbGpPWpGaD
Frovatriptan—Anaphylactic shock—Timolol—migraine	8.58e-05	0.000903	CcSEcCtD
Frovatriptan—Somnolence—Valproic Acid—migraine	8.57e-05	0.000902	CcSEcCtD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—migraine	8.52e-05	0.00156	CbGpPWpGaD
Frovatriptan—Headache—Verapamil—migraine	8.52e-05	0.000896	CcSEcCtD
Frovatriptan—Chills—Topiramate—migraine	8.49e-05	0.000894	CcSEcCtD
Frovatriptan—Dyspepsia—Valproic Acid—migraine	8.48e-05	0.000893	CcSEcCtD
Frovatriptan—Convulsion—Gabapentin—migraine	8.48e-05	0.000893	CcSEcCtD
Frovatriptan—HTR1A—GPCR ligand binding—HTR2B—migraine	8.45e-05	0.00155	CbGpPWpGaD
Frovatriptan—Shock—Timolol—migraine	8.44e-05	0.000888	CcSEcCtD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	8.44e-05	0.00154	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—RAMP1—migraine	8.42e-05	0.00154	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CALCRL—migraine	8.42e-05	0.00154	CbGpPWpGaD
Frovatriptan—Decreased appetite—Valproic Acid—migraine	8.38e-05	0.000882	CcSEcCtD
Frovatriptan—Chest pain—Gabapentin—migraine	8.33e-05	0.000877	CcSEcCtD
Frovatriptan—Myalgia—Gabapentin—migraine	8.33e-05	0.000877	CcSEcCtD
Frovatriptan—Arthralgia—Gabapentin—migraine	8.33e-05	0.000877	CcSEcCtD
Frovatriptan—Fatigue—Valproic Acid—migraine	8.31e-05	0.000875	CcSEcCtD
Frovatriptan—Anxiety—Gabapentin—migraine	8.31e-05	0.000874	CcSEcCtD
Frovatriptan—Hyperhidrosis—Timolol—migraine	8.29e-05	0.000873	CcSEcCtD
Frovatriptan—Mental disorder—Topiramate—migraine	8.29e-05	0.000872	CcSEcCtD
Frovatriptan—Constipation—Valproic Acid—migraine	8.24e-05	0.000867	CcSEcCtD
Frovatriptan—Pain—Valproic Acid—migraine	8.24e-05	0.000867	CcSEcCtD
Frovatriptan—Malnutrition—Topiramate—migraine	8.24e-05	0.000867	CcSEcCtD
Frovatriptan—Discomfort—Gabapentin—migraine	8.24e-05	0.000867	CcSEcCtD
Frovatriptan—Anorexia—Timolol—migraine	8.18e-05	0.000861	CcSEcCtD
Frovatriptan—Dry mouth—Gabapentin—migraine	8.15e-05	0.000858	CcSEcCtD
Frovatriptan—Flatulence—Topiramate—migraine	8.12e-05	0.000854	CcSEcCtD
Frovatriptan—Tension—Topiramate—migraine	8.08e-05	0.000851	CcSEcCtD
Frovatriptan—Nausea—Verapamil—migraine	8.07e-05	0.00085	CcSEcCtD
Frovatriptan—Dysgeusia—Topiramate—migraine	8.07e-05	0.000849	CcSEcCtD
Frovatriptan—Confusional state—Gabapentin—migraine	8.06e-05	0.000848	CcSEcCtD
Frovatriptan—Nervousness—Topiramate—migraine	8e-05	0.000842	CcSEcCtD
Frovatriptan—Anaphylactic shock—Gabapentin—migraine	7.99e-05	0.000841	CcSEcCtD
Frovatriptan—Back pain—Topiramate—migraine	7.97e-05	0.000839	CcSEcCtD
Frovatriptan—Feeling abnormal—Valproic Acid—migraine	7.94e-05	0.000836	CcSEcCtD
Frovatriptan—Muscle spasms—Topiramate—migraine	7.92e-05	0.000833	CcSEcCtD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	7.89e-05	0.00144	CbGpPWpGaD
Frovatriptan—Gastrointestinal pain—Valproic Acid—migraine	7.88e-05	0.00083	CcSEcCtD
Frovatriptan—Shock—Gabapentin—migraine	7.86e-05	0.000827	CcSEcCtD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	7.84e-05	0.00144	CbGpPWpGaD
Frovatriptan—Musculoskeletal discomfort—Timolol—migraine	7.82e-05	0.000823	CcSEcCtD
Frovatriptan—Tachycardia—Gabapentin—migraine	7.8e-05	0.000821	CcSEcCtD
Frovatriptan—Insomnia—Timolol—migraine	7.76e-05	0.000817	CcSEcCtD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	7.73e-05	0.00141	CbGpPWpGaD
Frovatriptan—Hyperhidrosis—Gabapentin—migraine	7.72e-05	0.000813	CcSEcCtD
Frovatriptan—Tremor—Topiramate—migraine	7.72e-05	0.000812	CcSEcCtD
Frovatriptan—Paraesthesia—Timolol—migraine	7.7e-05	0.000811	CcSEcCtD
Frovatriptan—Dyspnoea—Timolol—migraine	7.65e-05	0.000805	CcSEcCtD
Frovatriptan—Ill-defined disorder—Topiramate—migraine	7.64e-05	0.000804	CcSEcCtD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.63e-05	0.0014	CbGpPWpGaD
Frovatriptan—Somnolence—Timolol—migraine	7.63e-05	0.000803	CcSEcCtD
Frovatriptan—Body temperature increased—Valproic Acid—migraine	7.62e-05	0.000802	CcSEcCtD
Frovatriptan—Abdominal pain—Valproic Acid—migraine	7.62e-05	0.000802	CcSEcCtD
Frovatriptan—Anorexia—Gabapentin—migraine	7.62e-05	0.000802	CcSEcCtD
Frovatriptan—Agitation—Topiramate—migraine	7.57e-05	0.000797	CcSEcCtD
Frovatriptan—Dyspepsia—Timolol—migraine	7.55e-05	0.000795	CcSEcCtD
Frovatriptan—Decreased appetite—Timolol—migraine	7.46e-05	0.000785	CcSEcCtD
Frovatriptan—Malaise—Topiramate—migraine	7.43e-05	0.000782	CcSEcCtD
Frovatriptan—Vertigo—Topiramate—migraine	7.4e-05	0.000779	CcSEcCtD
Frovatriptan—Fatigue—Timolol—migraine	7.4e-05	0.000779	CcSEcCtD
Frovatriptan—Syncope—Topiramate—migraine	7.39e-05	0.000777	CcSEcCtD
Frovatriptan—HTR1D—GPCR ligand binding—HTR1B—migraine	7.38e-05	0.00135	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	7.36e-05	0.00135	CbGpPWpGaD
Frovatriptan—Pain—Timolol—migraine	7.34e-05	0.000772	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Gabapentin—migraine	7.28e-05	0.000766	CcSEcCtD
Frovatriptan—Palpitations—Topiramate—migraine	7.28e-05	0.000766	CcSEcCtD
Frovatriptan—Loss of consciousness—Topiramate—migraine	7.24e-05	0.000762	CcSEcCtD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.23e-05	0.00132	CbGpPWpGaD
Frovatriptan—Insomnia—Gabapentin—migraine	7.23e-05	0.000761	CcSEcCtD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—migraine	7.2e-05	0.00132	CbGpPWpGaD
Frovatriptan—Paraesthesia—Gabapentin—migraine	7.17e-05	0.000755	CcSEcCtD
Frovatriptan—Convulsion—Topiramate—migraine	7.14e-05	0.000751	CcSEcCtD
Frovatriptan—Dyspnoea—Gabapentin—migraine	7.12e-05	0.00075	CcSEcCtD
Frovatriptan—Somnolence—Gabapentin—migraine	7.1e-05	0.000748	CcSEcCtD
Frovatriptan—HTR1D—GPCR ligand binding—HTR1A—migraine	7.1e-05	0.0013	CbGpPWpGaD
Frovatriptan—Hypersensitivity—Valproic Acid—migraine	7.1e-05	0.000747	CcSEcCtD
Frovatriptan—Feeling abnormal—Timolol—migraine	7.07e-05	0.000744	CcSEcCtD
Frovatriptan—HTR1A—GPCR downstream signaling—CALCRL—migraine	7.07e-05	0.00129	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—RAMP1—migraine	7.07e-05	0.00129	CbGpPWpGaD
Frovatriptan—Dyspepsia—Gabapentin—migraine	7.03e-05	0.00074	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Timolol—migraine	7.02e-05	0.000738	CcSEcCtD
Frovatriptan—Myalgia—Topiramate—migraine	7.01e-05	0.000738	CcSEcCtD
Frovatriptan—Chest pain—Topiramate—migraine	7.01e-05	0.000738	CcSEcCtD
Frovatriptan—Arthralgia—Topiramate—migraine	7.01e-05	0.000738	CcSEcCtD
Frovatriptan—HTR1D—GPCR ligand binding—NPS—migraine	7e-05	0.00128	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—TAC1—migraine	7e-05	0.00128	CbGpPWpGaD
Frovatriptan—Anxiety—Topiramate—migraine	6.99e-05	0.000735	CcSEcCtD
Frovatriptan—HTR1B—GPCR ligand binding—HTR1A—migraine	6.95e-05	0.00127	CbGpPWpGaD
Frovatriptan—Decreased appetite—Gabapentin—migraine	6.95e-05	0.000731	CcSEcCtD
Frovatriptan—Discomfort—Topiramate—migraine	6.93e-05	0.000729	CcSEcCtD
Frovatriptan—Asthenia—Valproic Acid—migraine	6.92e-05	0.000728	CcSEcCtD
Frovatriptan—Fatigue—Gabapentin—migraine	6.89e-05	0.000725	CcSEcCtD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	6.87e-05	0.00126	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HTR2C—migraine	6.86e-05	0.00126	CbGpPWpGaD
Frovatriptan—Dry mouth—Topiramate—migraine	6.86e-05	0.000722	CcSEcCtD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.85e-05	0.00125	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.85e-05	0.00125	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—NPS—migraine	6.85e-05	0.00125	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—TAC1—migraine	6.85e-05	0.00125	CbGpPWpGaD
Frovatriptan—Constipation—Gabapentin—migraine	6.83e-05	0.000719	CcSEcCtD
Frovatriptan—Pain—Gabapentin—migraine	6.83e-05	0.000719	CcSEcCtD
Frovatriptan—Pruritus—Valproic Acid—migraine	6.82e-05	0.000718	CcSEcCtD
Frovatriptan—Abdominal pain—Timolol—migraine	6.78e-05	0.000714	CcSEcCtD
Frovatriptan—Body temperature increased—Timolol—migraine	6.78e-05	0.000714	CcSEcCtD
Frovatriptan—Confusional state—Topiramate—migraine	6.78e-05	0.000713	CcSEcCtD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR1D—migraine	6.74e-05	0.00123	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.72e-05	0.00123	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR2C—migraine	6.72e-05	0.00123	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—EDNRA—migraine	6.67e-05	0.00122	CbGpPWpGaD
Frovatriptan—Shock—Topiramate—migraine	6.61e-05	0.000696	CcSEcCtD
Frovatriptan—Diarrhoea—Valproic Acid—migraine	6.59e-05	0.000694	CcSEcCtD
Frovatriptan—Feeling abnormal—Gabapentin—migraine	6.58e-05	0.000693	CcSEcCtD
Frovatriptan—Tachycardia—Topiramate—migraine	6.56e-05	0.000691	CcSEcCtD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.54e-05	0.0012	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—EDNRA—migraine	6.53e-05	0.0012	CbGpPWpGaD
Frovatriptan—Gastrointestinal pain—Gabapentin—migraine	6.53e-05	0.000688	CcSEcCtD
Frovatriptan—Hyperhidrosis—Topiramate—migraine	6.5e-05	0.000684	CcSEcCtD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	6.45e-05	0.00118	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CALCA—migraine	6.42e-05	0.00118	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—RAMP1—migraine	6.42e-05	0.00117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CALCRL—migraine	6.42e-05	0.00117	CbGpPWpGaD
Frovatriptan—Anorexia—Topiramate—migraine	6.41e-05	0.000674	CcSEcCtD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2B—migraine	6.4e-05	0.00117	CbGpPWpGaD
Frovatriptan—Dizziness—Valproic Acid—migraine	6.37e-05	0.000671	CcSEcCtD
Frovatriptan—Hypersensitivity—Timolol—migraine	6.32e-05	0.000665	CcSEcCtD
Frovatriptan—Abdominal pain—Gabapentin—migraine	6.32e-05	0.000665	CcSEcCtD
Frovatriptan—Body temperature increased—Gabapentin—migraine	6.32e-05	0.000665	CcSEcCtD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	6.32e-05	0.00116	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CALCA—migraine	6.29e-05	0.00115	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2B—migraine	6.27e-05	0.00115	CbGpPWpGaD
Frovatriptan—Asthenia—Timolol—migraine	6.16e-05	0.000648	CcSEcCtD
Frovatriptan—Vomiting—Valproic Acid—migraine	6.13e-05	0.000645	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Topiramate—migraine	6.12e-05	0.000645	CcSEcCtD
Frovatriptan—HTR1B—Signaling by GPCR—HTR1D—migraine	6.12e-05	0.00112	CbGpPWpGaD
Frovatriptan—Insomnia—Topiramate—migraine	6.08e-05	0.00064	CcSEcCtD
Frovatriptan—Pruritus—Timolol—migraine	6.07e-05	0.000639	CcSEcCtD
Frovatriptan—Headache—Valproic Acid—migraine	6.04e-05	0.000635	CcSEcCtD
Frovatriptan—Paraesthesia—Topiramate—migraine	6.04e-05	0.000635	CcSEcCtD
Frovatriptan—HTR1D—GPCR ligand binding—HTR7—migraine	6.01e-05	0.0011	CbGpPWpGaD
Frovatriptan—Dyspnoea—Topiramate—migraine	5.99e-05	0.000631	CcSEcCtD
Frovatriptan—Somnolence—Topiramate—migraine	5.98e-05	0.000629	CcSEcCtD
Frovatriptan—Dyspepsia—Topiramate—migraine	5.92e-05	0.000623	CcSEcCtD
Frovatriptan—Hypersensitivity—Gabapentin—migraine	5.89e-05	0.00062	CcSEcCtD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.89e-05	0.00108	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR7—migraine	5.88e-05	0.00108	CbGpPWpGaD
Frovatriptan—Diarrhoea—Timolol—migraine	5.87e-05	0.000618	CcSEcCtD
Frovatriptan—Decreased appetite—Topiramate—migraine	5.84e-05	0.000615	CcSEcCtD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2B—migraine	5.81e-05	0.00106	CbGpPWpGaD
Frovatriptan—Fatigue—Topiramate—migraine	5.8e-05	0.00061	CcSEcCtD
Frovatriptan—Constipation—Topiramate—migraine	5.75e-05	0.000605	CcSEcCtD
Frovatriptan—Pain—Topiramate—migraine	5.75e-05	0.000605	CcSEcCtD
Frovatriptan—Asthenia—Gabapentin—migraine	5.73e-05	0.000603	CcSEcCtD
Frovatriptan—Nausea—Valproic Acid—migraine	5.73e-05	0.000603	CcSEcCtD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2B—migraine	5.69e-05	0.00104	CbGpPWpGaD
Frovatriptan—Dizziness—Timolol—migraine	5.67e-05	0.000597	CcSEcCtD
Frovatriptan—Pruritus—Gabapentin—migraine	5.65e-05	0.000595	CcSEcCtD
Frovatriptan—Feeling abnormal—Topiramate—migraine	5.54e-05	0.000583	CcSEcCtD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.53e-05	0.00101	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR1B—migraine	5.5e-05	0.00101	CbGpPWpGaD
Frovatriptan—Gastrointestinal pain—Topiramate—migraine	5.5e-05	0.000579	CcSEcCtD
Frovatriptan—Diarrhoea—Gabapentin—migraine	5.47e-05	0.000575	CcSEcCtD
Frovatriptan—Vomiting—Timolol—migraine	5.46e-05	0.000574	CcSEcCtD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.41e-05	0.00099	CbGpPWpGaD
Frovatriptan—Headache—Timolol—migraine	5.38e-05	0.000566	CcSEcCtD
Frovatriptan—Abdominal pain—Topiramate—migraine	5.31e-05	0.000559	CcSEcCtD
Frovatriptan—Body temperature increased—Topiramate—migraine	5.31e-05	0.000559	CcSEcCtD
Frovatriptan—Dizziness—Gabapentin—migraine	5.28e-05	0.000556	CcSEcCtD
Frovatriptan—HTR1A—GPCR ligand binding—NPS—migraine	5.22e-05	0.000955	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—TAC1—migraine	5.22e-05	0.000955	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR1D—migraine	5.13e-05	0.00094	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR2C—migraine	5.12e-05	0.000936	CbGpPWpGaD
Frovatriptan—Nausea—Timolol—migraine	5.1e-05	0.000536	CcSEcCtD
Frovatriptan—HTR1D—Signaling Pathways—RAMP1—migraine	5.08e-05	0.00093	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CALCRL—migraine	5.08e-05	0.00093	CbGpPWpGaD
Frovatriptan—Vomiting—Gabapentin—migraine	5.08e-05	0.000535	CcSEcCtD
Frovatriptan—Headache—Gabapentin—migraine	5.01e-05	0.000527	CcSEcCtD
Frovatriptan—HTR1A—GPCR ligand binding—EDNRA—migraine	4.98e-05	0.000911	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RAMP1—migraine	4.98e-05	0.000911	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CALCRL—migraine	4.98e-05	0.000911	CbGpPWpGaD
Frovatriptan—Hypersensitivity—Topiramate—migraine	4.95e-05	0.000521	CcSEcCtD
Frovatriptan—Asthenia—Topiramate—migraine	4.82e-05	0.000508	CcSEcCtD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.81e-05	0.000881	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CALCA—migraine	4.79e-05	0.000877	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2B—migraine	4.77e-05	0.000874	CbGpPWpGaD
Frovatriptan—Pruritus—Topiramate—migraine	4.76e-05	0.000501	CcSEcCtD
Frovatriptan—Nausea—Gabapentin—migraine	4.75e-05	0.0005	CcSEcCtD
Frovatriptan—HTR1A—Signaling by GPCR—HTR1D—migraine	4.66e-05	0.000853	CbGpPWpGaD
Frovatriptan—Diarrhoea—Topiramate—migraine	4.6e-05	0.000484	CcSEcCtD
Frovatriptan—HTR1A—GPCR ligand binding—HTR7—migraine	4.48e-05	0.00082	CbGpPWpGaD
Frovatriptan—Dizziness—Topiramate—migraine	4.45e-05	0.000468	CcSEcCtD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2B—migraine	4.33e-05	0.000793	CbGpPWpGaD
Frovatriptan—Vomiting—Topiramate—migraine	4.27e-05	0.00045	CcSEcCtD
Frovatriptan—Headache—Topiramate—migraine	4.21e-05	0.000443	CcSEcCtD
Frovatriptan—HTR1D—GPCR ligand binding—HTR2A—migraine	4.21e-05	0.00077	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR1B—migraine	4.17e-05	0.000763	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.12e-05	0.000754	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR2A—migraine	4.12e-05	0.000754	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR1A—migraine	4.01e-05	0.000735	CbGpPWpGaD
Frovatriptan—Nausea—Topiramate—migraine	3.99e-05	0.00042	CcSEcCtD
Frovatriptan—HTR1D—GPCR downstream signaling—NPS—migraine	3.95e-05	0.000723	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—TAC1—migraine	3.95e-05	0.000723	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR1A—migraine	3.93e-05	0.000719	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2C—migraine	3.88e-05	0.00071	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—NPS—migraine	3.87e-05	0.000708	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—TAC1—migraine	3.87e-05	0.000708	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2C—migraine	3.8e-05	0.000695	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CALCRL—migraine	3.79e-05	0.000694	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RAMP1—migraine	3.79e-05	0.000694	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR1B—migraine	3.79e-05	0.000693	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—EDNRA—migraine	3.77e-05	0.00069	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—EDNRA—migraine	3.69e-05	0.000676	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR1A—migraine	3.65e-05	0.000667	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CALCA—migraine	3.63e-05	0.000664	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR1D—migraine	3.62e-05	0.000662	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TAC1—migraine	3.59e-05	0.000657	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—NPS—migraine	3.59e-05	0.000657	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR1A—migraine	3.57e-05	0.000653	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	3.57e-05	0.000653	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	3.57e-05	0.000653	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CALCA—migraine	3.55e-05	0.000651	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2C—migraine	3.52e-05	0.000644	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—NPS—migraine	3.52e-05	0.000643	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TAC1—migraine	3.52e-05	0.000643	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2C—migraine	3.45e-05	0.000631	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2B—migraine	3.43e-05	0.000628	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EDNRA—migraine	3.42e-05	0.000627	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR7—migraine	3.4e-05	0.000621	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2B—migraine	3.36e-05	0.000615	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EDNRA—migraine	3.35e-05	0.000614	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR7—migraine	3.32e-05	0.000608	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CALCA—migraine	3.3e-05	0.000603	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CALCA—migraine	3.23e-05	0.000591	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR2A—migraine	3.14e-05	0.000574	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR1B—migraine	3.11e-05	0.000569	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—migraine	3.09e-05	0.000566	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR7—migraine	3.08e-05	0.000564	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LRP1—migraine	3.02e-05	0.000553	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR7—migraine	3.02e-05	0.000553	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LRP1—migraine	2.96e-05	0.000542	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—NPS—migraine	2.95e-05	0.00054	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—TAC1—migraine	2.95e-05	0.00054	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2C—migraine	2.89e-05	0.000529	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR1B—migraine	2.82e-05	0.000517	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—EDNRA—migraine	2.81e-05	0.000515	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR1D—migraine	2.75e-05	0.000504	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CALCA—migraine	2.71e-05	0.000496	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—NPS—migraine	2.68e-05	0.00049	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TAC1—migraine	2.68e-05	0.00049	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2C—migraine	2.63e-05	0.000481	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2B—migraine	2.56e-05	0.000469	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EDNRA—migraine	2.55e-05	0.000468	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR7—migraine	2.53e-05	0.000464	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CALCA—migraine	2.46e-05	0.00045	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2A—migraine	2.38e-05	0.000435	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2A—migraine	2.33e-05	0.000426	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOTCH4—migraine	2.32e-05	0.000424	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR7—migraine	2.3e-05	0.000421	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOTCH4—migraine	2.27e-05	0.000416	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LRP1—migraine	2.25e-05	0.000413	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR1B—migraine	2.24e-05	0.000409	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2A—migraine	2.16e-05	0.000395	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR1A—migraine	2.15e-05	0.000394	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PGR—migraine	2.12e-05	0.000388	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TAC1—migraine	2.12e-05	0.000388	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NPS—migraine	2.12e-05	0.000388	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2A—migraine	2.11e-05	0.000387	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR1A—migraine	2.11e-05	0.000386	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2C—migraine	2.08e-05	0.000381	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PGR—migraine	2.08e-05	0.00038	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TAC1—migraine	2.08e-05	0.00038	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NPS—migraine	2.08e-05	0.00038	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2C—migraine	2.04e-05	0.000373	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EDNRA—migraine	2.02e-05	0.00037	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EDNRA—migraine	1.98e-05	0.000363	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOTCH3—migraine	1.97e-05	0.000361	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CALCA—migraine	1.95e-05	0.000356	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOTCH3—migraine	1.93e-05	0.000353	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CALCA—migraine	1.91e-05	0.000349	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR7—migraine	1.82e-05	0.000333	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR7—migraine	1.78e-05	0.000326	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2A—migraine	1.77e-05	0.000325	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH4—migraine	1.73e-05	0.000317	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR1B—migraine	1.67e-05	0.000305	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2A—migraine	1.61e-05	0.000295	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PGR—migraine	1.58e-05	0.000289	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TAC1—migraine	1.58e-05	0.000289	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NPS—migraine	1.58e-05	0.000289	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFBR2—migraine	1.57e-05	0.000287	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2C—migraine	1.55e-05	0.000284	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFBR2—migraine	1.54e-05	0.000281	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EDNRA—migraine	1.51e-05	0.000276	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CACNA1A—migraine	1.49e-05	0.000273	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH3—migraine	1.47e-05	0.000269	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CALCA—migraine	1.45e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR7—migraine	1.36e-05	0.000249	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2A—migraine	1.28e-05	0.000233	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2A—migraine	1.25e-05	0.000229	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFBR2—migraine	1.17e-05	0.000214	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ESR1—migraine	1.13e-05	0.000207	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ESR1—migraine	1.11e-05	0.000203	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—migraine	9.52e-06	0.000174	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ESR1—migraine	8.45e-06	0.000155	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—migraine	4.93e-06	9.02e-05	CbGpPWpGaD
